DE2611690A1
(de)
*
|
1976-03-19 |
1977-09-22 |
Goedecke Ag |
Cyclische sulfonyloxyimide
|
JPS5776189U
(fr)
*
|
1980-10-28 |
1982-05-11 |
|
|
JPS5847580U
(ja)
*
|
1981-09-28 |
1983-03-30 |
本田技研工業株式会社 |
車両用荷物箱の取付構造
|
JPS6152583U
(fr)
*
|
1984-09-11 |
1986-04-09 |
|
|
JPS61139881U
(fr)
*
|
1985-02-21 |
1986-08-29 |
|
|
US4876279A
(en)
*
|
1986-05-05 |
1989-10-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
US4894476A
(en)
*
|
1988-05-02 |
1990-01-16 |
Warner-Lambert Company |
Gabapentin monohydrate and a process for producing the same
|
US4960931A
(en)
*
|
1988-05-02 |
1990-10-02 |
Warner-Lambert Company |
Gabapentin mohohydrate and a process for producing the same
|
YU162789A
(en)
*
|
1988-09-01 |
1990-12-31 |
Lonza Ag |
2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones
|
AU633612B2
(en)
*
|
1989-08-25 |
1993-02-04 |
Warner-Lambert Company |
Improved process for cyclic amino acid anticonvulsant compounds
|
US5132451A
(en)
*
|
1989-08-25 |
1992-07-21 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
US5319135A
(en)
*
|
1989-08-25 |
1994-06-07 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
DE3928184A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
|
DE3928183A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
DE3928182A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von gabapentin
|
US5260467A
(en)
*
|
1989-11-16 |
1993-11-09 |
Pfizer Inc. |
Glutaric acid derivatives and preparation thereof
|
US5149870A
(en)
*
|
1989-11-16 |
1992-09-22 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl)cyclohexane acetic acid
|
GB8925933D0
(en)
*
|
1989-11-16 |
1990-01-04 |
Pfizer Ltd |
Glutaric acid derivatives and preparation thereof
|
US5157138A
(en)
*
|
1989-11-16 |
1992-10-20 |
Pfizer, Inc. |
Glutaric acid derivatives and preparation thereof
|
FI905584A
(fi)
*
|
1989-11-16 |
1991-05-17 |
Lonza Ag |
Foerfarande foer framstaellning av 1-(aminometyl)cyklohexanaettikssyra.
|
US5136091A
(en)
*
|
1989-11-16 |
1992-08-04 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl) cyclohexane acetic acid
|
US5084479A
(en)
*
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
US5025035A
(en)
*
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
US5792796A
(en)
*
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
US5510381A
(en)
*
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
NZ326669A
(en)
*
|
1996-02-07 |
2001-05-25 |
Warner Lambert Co |
Thiopyran or pyran derivatives useful as pharmaceutical agents
|
US6103932A
(en)
*
|
1996-03-14 |
2000-08-15 |
Warner-Lambert Company |
Substituted cyclic amino acids as pharmaceutical agents
|
AU731279B2
(en)
*
|
1996-03-14 |
2001-03-29 |
Warner-Lambert Company |
Novel bridged cyclic amino acids as pharmaceutical agents
|
WO1998003167A1
(fr)
|
1996-07-24 |
1998-01-29 |
Warner-Lambert Company |
Isobutylgaba et ses derives utilises pour le traitement de la douleur
|
EP0937032B1
(fr)
*
|
1996-10-23 |
2007-05-09 |
Warner-Lambert Company LLC |
Acides aminobutyriques gamma substitues utilises comme agents pharmaceutiques
|
US6255526B1
(en)
|
1996-12-24 |
2001-07-03 |
Teva Pharmaceutical Industries Ltd. |
Preparation of gabapentin
|
IL119890A
(en)
*
|
1996-12-24 |
2002-03-10 |
Teva Pharma |
Gabapentin form iii and preparation of gabapentin form ii
|
HRP980342A2
(en)
*
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
WO1999008667A2
(fr)
|
1997-08-19 |
1999-02-25 |
Warner-Lambert Company |
Methodes de traitement d'etats physiologiques associes a la consommation, ou a des sequelles dues a la consommation de cocaine ou d'autres stimulants psychomoteurs
|
IL134165A0
(en)
*
|
1997-09-08 |
2001-04-30 |
Warner Lambert Co |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
WO1999018063A2
(fr)
|
1997-10-07 |
1999-04-15 |
Warner-Lambert Company |
Procede de preparation d'un compose anticonvulsif, aminoacide et cyclique
|
HUP0004310A3
(en)
*
|
1997-10-27 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
|
US6984659B2
(en)
*
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
US6545022B1
(en)
|
1997-12-16 |
2003-04-08 |
Pfizer Inc. |
4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
|
CU23028A3
(es)
|
1997-12-16 |
2005-02-23 |
Warner Lambert Co |
Aminas novedosas como agentes farmaceuticos.
|
PL341291A1
(en)
*
|
1997-12-16 |
2001-04-09 |
Warner Lambert Co |
1-substituted derivatives of 1-aminomethyl-ccycloalkanes (gabapentin analogues), their production and application of them in treating neurological disorders
|
CA2309354A1
(fr)
*
|
1998-01-23 |
1999-07-29 |
Leslie Magnus-Miller |
Gabapentine et ses derives pour le traitement de la douleur musculaire et squelettique
|
EP0974351A3
(fr)
*
|
1998-04-24 |
2000-12-13 |
Jouveinal |
Médicament pour la prévention et le traitement des dommages gastrointestinaux
|
KR100602047B1
(ko)
|
1998-05-15 |
2006-07-19 |
워너-램버트 캄파니 엘엘씨 |
감마-아미노부티르산 유도체의 안정화된 제약 제제 및그의 제조 방법
|
EP1077691B1
(fr)
*
|
1998-05-15 |
2008-09-10 |
Warner-Lambert Company LLC |
Compositions solides contenant des derives de l'acide gamma-aminobutyrique, et procede de preparation associe
|
ES2137137B1
(es)
*
|
1998-05-25 |
2000-08-16 |
Medichem Sa |
Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
|
KR20010043831A
(ko)
|
1998-05-26 |
2001-05-25 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
칼슘 채널의 알파2델타 서브유닛에 대한 친화력이 있는구조적으로 한정된 아미노산 화합물
|
ITMI981535A1
(it)
*
|
1998-07-03 |
2000-01-03 |
Zambon Spa |
Processo per la preparazione di gabapentina
|
US20030045500A1
(en)
*
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
FR2781793B1
(fr)
|
1998-08-03 |
2001-07-20 |
Prographarm Lab |
Procede de fabrication de granules de gabapentine enrobes
|
HU225502B1
(en)
*
|
1998-12-29 |
2007-01-29 |
Richter Gedeon Vegyeszet |
Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
|
IT1311984B1
(it)
|
1999-03-26 |
2002-03-22 |
Bioindustria Lab Italiano Medi |
Procedimento per la preparzione di gabapentin.
|
WO2000061188A1
(fr)
*
|
1999-04-09 |
2000-10-19 |
Euro-Celtique S.A. |
Composition de blocage du canal sodique et leur utilisation
|
CA2371089A1
(fr)
*
|
1999-05-28 |
2000-12-07 |
Warner-Lambert Company |
Analogues de gaba substitues par 3-heteroarylalkyle
|
US6710190B1
(en)
|
1999-05-28 |
2004-03-23 |
Warner-Lambert Company |
3-heteroarylalkyl substituted gaba analogs
|
US7164034B2
(en)
*
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
US20080207755A1
(en)
*
|
2000-05-31 |
2008-08-28 |
Pfizer Inc |
Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
|
BR0011727A
(pt)
*
|
1999-06-10 |
2002-03-05 |
Warner Lambert Co |
ácidos 3-propil gama-aminobutìricos mono- e dissubstituìdos
|
US6294198B1
(en)
|
1999-08-24 |
2001-09-25 |
Purepac Pharmaceutical Co. |
Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
|
HN2000000224A
(es)
*
|
1999-10-20 |
2001-04-11 |
Warner Lambert Co |
Aminoacidos biciclicos como agentes farmaceuticos
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
US6531509B2
(en)
|
2000-06-16 |
2003-03-11 |
Teva Pharmaceutical Industries Ltd. |
Stable gabapentin containing more than 20 ppm of chlorine ion
|
EP1384473A1
(fr)
*
|
2000-06-16 |
2004-01-28 |
Teva Pharmaceutical Industries Ltd. |
Gabapentin stable contenant plus de 20 ppm d'ions chlore
|
IL153441A0
(en)
*
|
2000-06-16 |
2003-07-06 |
Teva Pharma |
Stable gabapentin having ph within a controlled range
|
HUP0300833A3
(en)
*
|
2000-06-26 |
2009-08-28 |
Warner Lambert Co |
Gabapentin analogues for treating sleep disorders
|
GB2364049A
(en)
*
|
2000-06-28 |
2002-01-16 |
Warner Lambert Co |
Cyclic ketones and their use in the synthesis of amino acids
|
CA2421990C
(fr)
*
|
2000-09-14 |
2009-11-03 |
Gruenenthal Gmbh |
Acides .beta.-thioamines
|
WO2002032376A2
(fr)
*
|
2000-10-06 |
2002-04-25 |
Xenoport, Inc. |
Conjugues d'acides biliaires permettant de fournir des concentrations systemiques regulieres de medicaments
|
EP1343805A4
(fr)
*
|
2000-10-06 |
2005-07-20 |
Xenoport Inc |
Composes derives d'acide biliaire assurant des concentrations systemiques prolongees de medicaments apres administration par voie orale
|
US6620829B2
(en)
*
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
IT1319234B1
(it)
*
|
2000-10-23 |
2003-09-26 |
Zambon Spa |
Processo di preparazione di gabapentina.
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
PL365569A1
(en)
*
|
2000-11-02 |
2005-01-10 |
Teva Pharmaceutical Industries Ltd. |
Improved process for production of gabapentin intermediate
|
CN1477976A
(zh)
*
|
2000-11-30 |
2004-02-25 |
�Ʒ� |
Gaba激动剂与醛糖还原酶抑制剂的组合
|
EE200300248A
(et)
*
|
2000-11-30 |
2003-10-15 |
Pfizer Products Inc. |
GABA agonistide ja sorbitooldehüdrogenaasi inhibiitorite kombinatsioon
|
IT1319674B1
(it)
*
|
2000-12-01 |
2003-10-23 |
Erregierre Spa |
Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico.
|
WO2002074727A1
(fr)
*
|
2001-03-16 |
2002-09-26 |
Solchem Italiana S.P.A. |
Procede de preparation d'acides amines cycliques
|
ITMI20011132A1
(it)
|
2001-05-29 |
2002-11-29 |
Procos Spa |
Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
US6818787B2
(en)
*
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
IL159299A0
(en)
*
|
2001-06-11 |
2004-06-01 |
Xenoport Inc |
Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
US7186855B2
(en)
*
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
AU2002345638A1
(en)
*
|
2001-06-11 |
2002-12-23 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
IL144066A0
(en)
*
|
2001-06-28 |
2002-04-21 |
Bromine Compounds Ltd |
Process for the preparation of 1,1-cyclohexane diacetic monoamide
|
ITMI20011772A1
(it)
|
2001-08-10 |
2003-02-10 |
A M S A Anonima Materie Sint E |
Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide)
|
WO2003020273A2
(fr)
|
2001-09-03 |
2003-03-13 |
Newron Pharmaceuticals Spa |
Composition pharmaceutique comprenant de la gabapentine ou un analogue de celle-ci et un $g(a)-aminoamide, et utilisation analgesique de ladite composition
|
US6800782B2
(en)
*
|
2001-10-09 |
2004-10-05 |
Warner-Lambert Co. |
Anhydrous crystalline forms of gabapentin
|
US20070184104A1
(en)
*
|
2001-10-25 |
2007-08-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
TWI312285B
(en)
*
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
US7612112B2
(en)
*
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
ITMI20012750A1
(it)
|
2001-12-21 |
2003-06-21 |
Procos Spa |
Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
|
US20030119908A1
(en)
*
|
2001-12-21 |
2003-06-26 |
Zambon Group S.P.A. |
Stable gabapentin compositions
|
CA2474000A1
(fr)
*
|
2002-01-31 |
2003-08-07 |
Warner-Lambert Company Llc |
Ligands alpha 2 delta dans le traitement des acouphenes
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
AU2002316231A1
(en)
*
|
2002-02-19 |
2003-09-29 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
WO2003080588A1
(fr)
|
2002-03-20 |
2003-10-02 |
Xenoport |
Promedicaments 1-(acyloxy)-alkyle cyclique d'analogues de l'acide gamma-aminobutyrique, leurs compositions et leurs utilisations
|
AU2003262383A1
(en)
*
|
2002-04-16 |
2003-11-03 |
Taro Pharmaceutical Industries Ltd. |
Process for preparing gabapentin
|
WO2003094842A2
(fr)
*
|
2002-05-07 |
2003-11-20 |
A & D Bioscience, Inc. |
Conjugues comprenant un medicament agissant sur le systeme nerveux central, lequel medicament est lie a un acide glucuronique ou a une glucosamine par l'intermediaire d'une liaison amide, et utilisations correspondantes
|
AU2003243180A1
(en)
*
|
2002-05-17 |
2003-12-12 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
CA2488566A1
(fr)
*
|
2002-06-27 |
2004-01-08 |
Warner-Lambert Company Llc |
Methode de traitement du trouble d'hyperactivite avec deficit de l'attention
|
CA2395931A1
(fr)
*
|
2002-08-07 |
2004-02-07 |
Bernard Charles Sherman |
Compositions solides comportant du gabapentin et ayant une meilleure stabilite
|
US7053122B2
(en)
*
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
US20040092591A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Blakemore David Clive |
Therapeutic use of fused bicyclic or tricyclic amino acids
|
US20040092522A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
ITMI20022071A1
(it)
*
|
2002-10-01 |
2004-04-02 |
Erregierre Spa |
Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
|
US7659305B2
(en)
*
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
DE60230552D1
(de)
*
|
2002-11-18 |
2009-02-05 |
Nicholas Piramal India Ltd |
Verbessertes verfahren zur herstellung von gabapentin
|
WO2004046108A1
(fr)
*
|
2002-11-20 |
2004-06-03 |
Hikal Ltd. |
Amelioration apportee a un procede de preparation de gabalactame
|
US20040162351A1
(en)
*
|
2002-12-11 |
2004-08-19 |
Gallop Mark A. |
Orally administered dosage forms of fused GABA analog prodrugs having reduced toxicity
|
AU2003297927A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
WO2004054564A1
(fr)
*
|
2002-12-13 |
2004-07-01 |
Warner-Lambert Company Llc |
Analogues de gabapentine pour le traitement de la fibromyalgie et d'autres troubles connexes
|
CA2451267A1
(fr)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Utilisations pharmaceutiques de ligands alpha2delta
|
KR20050085563A
(ko)
|
2002-12-13 |
2005-08-29 |
워너-램버트 캄파니 엘엘씨 |
하부요로증상을 치료하기 위한 알파-2-델타 리간드
|
US20040180958A1
(en)
*
|
2002-12-13 |
2004-09-16 |
Taylor Charles Price |
Method of treatment
|
CA2505788A1
(fr)
*
|
2002-12-13 |
2004-07-01 |
Warner-Lambert Company Llc |
Derives de pregabalin pour le traitement de la fibromyalgie et d'autres troubles
|
MXPA05006209A
(es)
*
|
2002-12-13 |
2005-08-19 |
Warner Lambert Co |
Pregabalina y sus derivados para el tratamiento de fibromialgia y otros trastornos relacionados.
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
CA2513150A1
(fr)
*
|
2003-01-22 |
2004-08-05 |
Warner-Lambert Company Llc |
Derives d'acides beta-amines de cyclopropyle
|
CA2518218A1
(fr)
*
|
2003-03-07 |
2004-09-16 |
Warner-Lambert Company Llc |
Derives de .beta.-aminoacides substitues par tetrazole et oxadiazolone
|
EP1622603A4
(fr)
*
|
2003-03-25 |
2010-03-24 |
Kiel Lab Inc |
Sels d'acide phenolique de gabapentine en formes posologiques solides et procedes d'utilisation
|
WO2004093866A1
(fr)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Procede permettant de preparer des sels d'acide phenolique de gabapentine
|
EP1628656B1
(fr)
*
|
2003-03-25 |
2008-10-15 |
Kiel Laboratories, Inc. |
Tannate de gabapentine sous une forme galenique liquide ou semi-solide
|
NZ543138A
(en)
*
|
2003-03-31 |
2009-02-28 |
Xenoport Inc |
Treating or preventing hot flashes using prodrugs of GABA analogs
|
WO2004091278A2
(fr)
*
|
2003-04-11 |
2004-10-28 |
Transform Pharmaceuticals, Inc. |
Compositions de gabapentine
|
ITMI20030825A1
(it)
*
|
2003-04-18 |
2004-10-19 |
Farchemia Srl |
Procedimento per la preparazione di gabapentin esente da
|
WO2004093780A2
(fr)
*
|
2003-04-21 |
2004-11-04 |
Matrix Laboratories Ltd |
Processus de preparation de gabapentine forme ii
|
JP2006528676A
(ja)
*
|
2003-05-16 |
2006-12-21 |
ファイザー・プロダクツ・インク |
非定形型抗精神病薬と、gaba調節薬及び/又は抗痙攣薬の治療上の組合せ
|
MXPA05013754A
(es)
*
|
2003-06-19 |
2006-03-08 |
Pfizer Prod Inc |
Una preparacion biocatalitica del acido 1-cianociclohexanoacetico.
|
US7169812B2
(en)
*
|
2003-07-01 |
2007-01-30 |
Medtronic, Inc. |
Process for producing injectable gabapentin compositions
|
CA2572324A1
(fr)
*
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combinaison d'un inhibiteur allosterique de la metalloproteinase-13 matricielle et d'un ligand au recepteur alpha-2-delta
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
WO2005046566A2
(fr)
*
|
2003-08-04 |
2005-05-26 |
Sun Pharmaceutical Industries Limited |
Composition pharmaceutique stable
|
US20050043407A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
WO2005025562A1
(fr)
*
|
2003-09-11 |
2005-03-24 |
Xenoport, Inc. |
Traitement et/ou prevention de l'incontinence urinaire et promedicaments des analogues gaba
|
ATE449633T1
(de)
|
2003-09-12 |
2009-12-15 |
Pfizer |
Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
|
KR20060087560A
(ko)
*
|
2003-09-12 |
2006-08-02 |
워너-램버트 캄파니 엘엘씨 |
알파-2-델타 리간드 및 ssri 및/또는 snri를포함하는 우울증 및 불안 장애 치료용 조합물
|
NZ579515A
(en)
*
|
2003-09-17 |
2011-09-30 |
Xenoport Inc |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
SI1677767T1
(sl)
|
2003-10-14 |
2011-11-30 |
Xenoport Inc |
Kristalinična oblika analoga gama-aminomaslene kisline
|
ITMI20032165A1
(it)
*
|
2003-11-11 |
2005-05-12 |
Zambon Spa |
Processo di preparazione di gabapentina
|
WO2005060968A1
(fr)
|
2003-12-11 |
2005-07-07 |
Sepracor Inc. |
Combinaison d'un sedatif et d'un modulateur des neurotransmetteurs, et methodes permettant d'ameliorer la qualite du sommeil et de traiter la depression
|
JP2007537151A
(ja)
*
|
2004-01-29 |
2007-12-20 |
ファイザー・プロダクツ・インク |
γ−アミノ酪酸モジュレータと5−HT1B受容体アンタゴニストとの組合せ
|
US20050187295A1
(en)
*
|
2004-02-19 |
2005-08-25 |
Surendra Kalyan |
Processes for the preparation of gabapentin
|
EP2172445A1
(fr)
*
|
2004-03-17 |
2010-04-07 |
Hikal Limited |
Cis (Z) 4-t-butylgabapentine et sa synthèse
|
ITMI20040579A1
(it)
*
|
2004-03-25 |
2004-06-25 |
Zambon Spa |
Processo di preparazione di gabapentina
|
EP1737473A4
(fr)
*
|
2004-04-19 |
2009-08-26 |
Noven Therapeutics Llc |
Combinaisons de lithium et utilisations associees
|
KR20070029740A
(ko)
*
|
2004-06-09 |
2007-03-14 |
화이자 인코포레이티드 |
통증 치료를 위한 레복세틴의 용도
|
GB0416228D0
(en)
*
|
2004-07-20 |
2004-08-25 |
Sandoz Ind Products S A |
Process for the preparation of gabapentin
|
GB0419849D0
(en)
*
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
NZ553970A
(en)
*
|
2004-09-10 |
2010-01-29 |
Newron Pharm Spa |
Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators
|
AU2005301970B2
(en)
*
|
2004-11-04 |
2011-06-02 |
Arbor Pharmaceuticals, Llc |
Gabapentin prodrug sustained release oral dosage forms
|
EP2258357A3
(fr)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenèse avec inhibiteur de l'acetylcholinestérase
|
CA2620333A1
(fr)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenese par modulation du recepteur muscarinique
|
US8378117B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
US7825151B2
(en)
*
|
2005-09-23 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
WO2007035945A1
(fr)
|
2005-09-23 |
2007-03-29 |
Janssen Pharmaceutica, N.V. |
Modulateurs cannabinoïdes de type tétrahydrocyclopentylpyrazole
|
KR20080066924A
(ko)
*
|
2005-09-23 |
2008-07-17 |
얀센 파마슈티카 엔.브이. |
헥사하이드로 사이클로옥틸 피라졸 카나비노이드모듈레이터
|
US8378096B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
AU2006295121B2
(en)
*
|
2005-09-23 |
2011-10-27 |
Janssen Pharmaceutica, N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
US7985756B2
(en)
|
2005-10-21 |
2011-07-26 |
Braincells Inc. |
Modulation of neurogenesis by PDE inhibition
|
US20070112017A1
(en)
*
|
2005-10-31 |
2007-05-17 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
US20070117858A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Mingde Xia |
Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
|
US20090176882A1
(en)
*
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
EP1979593B1
(fr)
*
|
2006-02-03 |
2017-12-06 |
Rolls-Royce Corporation |
Systeme de carburant de moteur a turbine a gaz dote d'une soupape doseuse de carburant
|
EP1820502A1
(fr)
|
2006-02-10 |
2007-08-22 |
Laboratorios Del Dr. Esteve, S.A. |
Combinaisons de principes actifs comprenant de dérivés d' azolylcarbinol
|
WO2007095513A1
(fr)
*
|
2006-02-14 |
2007-08-23 |
Janssen Pharmaceutica, Nv |
Modulateurs cannabinoides de type tetrahydro-2h-indazole pyrazole
|
RU2008135907A
(ru)
*
|
2006-03-06 |
2010-04-20 |
Пфайзер Продактс Инк. (Us) |
Альфа-2-дельта лиганды для невосстановительного сна
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
WO2007112402A1
(fr)
*
|
2006-03-27 |
2007-10-04 |
Janssen Pharmaceutica N.V. |
Modulateurs cannabinoïdes de type tétrahydro-1h-1,2,6-triazaazulènes
|
US20070254911A1
(en)
*
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
MX2008014320A
(es)
|
2006-05-09 |
2009-03-25 |
Braincells Inc |
Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
|
JP2009536669A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス,インコーポレイティド |
アンジオテンシン調節による神経新生
|
US7442834B2
(en)
*
|
2006-06-12 |
2008-10-28 |
Zhejiang Chiral Medicine Chemicals Co., Ltd. |
Process suitable for industrial scale production of gabapentin
|
WO2008004115A1
(fr)
*
|
2006-06-30 |
2008-01-10 |
Zach System S.P.A. |
Procédé de préparation de la gabapentine
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
JP2010512314A
(ja)
*
|
2006-12-08 |
2010-04-22 |
ゼノポート,インコーポレーテッド |
疾患を治療するためのgabaアナログのプロドラッグの使用
|
EA017171B1
(ru)
|
2006-12-22 |
2012-10-30 |
Рекордати Айерленд Лимитед |
КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ αδ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП)
|
CN101631768A
(zh)
*
|
2007-03-15 |
2010-01-20 |
太阳医药高级研究有限公司 |
新型前药
|
WO2008157408A2
(fr)
*
|
2007-06-15 |
2008-12-24 |
Xenoport, Inc. |
Utilisation de promédicaments d'analogues de gaba, agents antispasticité et promédicaments d'agonistes de récepteur de gaba b pour traiter la spasticité
|
US7943653B2
(en)
*
|
2007-08-13 |
2011-05-17 |
Janssen Pharmaceutica N.V. |
Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
|
US20090062392A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched gabapentin
|
TW200936123A
(en)
*
|
2007-11-06 |
2009-09-01 |
Xenoport Inc |
Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
|
TWI369202B
(en)
*
|
2008-01-25 |
2012-08-01 |
Xenoport Inc |
Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
|
EP2250148B1
(fr)
|
2008-01-25 |
2016-08-17 |
XenoPort, Inc. |
Forme cristalline de sels de calcium d'acide (3s)-aminomethyl-5-methyl-hexanoique et ses procedes d'utilisation
|
WO2009094577A2
(fr)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Formes mésophasiques de précurseurs d'acide (3s)-aminométhyl-5-méthyl-hexanoïque et procédés d'utilisation
|
EP2116539A1
(fr)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles en tant que ligands améliorant les effets analgésiques des opioïdes et réduisant leur dépendance
|
US20100190752A1
(en)
*
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
ES2589915T3
(es)
|
2008-10-08 |
2016-11-17 |
Xgene Pharmaceutical Inc |
Conjugados de GABA y métodos de utilización de los mismos
|
WO2010099200A1
(fr)
|
2009-02-24 |
2010-09-02 |
Nektar Therapeutics |
Conjugués oligomère-acides aminés
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
JP5815552B2
(ja)
|
2009-12-08 |
2015-11-17 |
ケース ウェスタン リザーブ ユニバーシティCase Westernreserve University |
眼疾患を治療する化合物および方法
|
EP2353591A1
(fr)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Ligands sigma pour la potentialisation de l'effet analgésique d'opioïdes et d'opiacés dans la douleur post-opératoire et en atténuant la dépendance
|
EP2368872A1
(fr)
|
2010-03-25 |
2011-09-28 |
Serichim S.r.l. |
Procédé de préparation de gabapentine
|
EP2388005A1
(fr)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Ligands sigma pour la prévention et/ou le traitement du vomissement induit par la chimiothérapie ou la radiothérapie
|
WO2011151708A1
(fr)
|
2010-06-01 |
2011-12-08 |
Rubicon Research Private Limited |
Formes posologiques à rétention gastrique d'analogues de gaba
|
US8431739B2
(en)
|
2010-06-14 |
2013-04-30 |
Divi's Laboratories, Ltd. |
Process for the preparation of gabapentin
|
US8946267B2
(en)
|
2010-07-30 |
2015-02-03 |
Toray Industries, Inc. |
Therapeutic agent or prophylactic agent for neuropathic pain
|
EP2415471A1
(fr)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Utilisation de ligands sigma dans l'hyperalgie induite par opioïdes
|
JP2013216580A
(ja)
*
|
2010-08-06 |
2013-10-24 |
Kyorin Pharmaceutical Co Ltd |
ビシクロ[2.2.2]オクチルアミン誘導体の製造方法
|
EP2524694A1
(fr)
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Utilisation de ligands sigma dans la douleur liée au diabète de type 2
|
EP2530072A1
(fr)
|
2011-06-03 |
2012-12-05 |
Lacer, S.A. |
Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
ITMI20131757A1
(it)
|
2013-10-22 |
2015-04-23 |
Zach System Spa |
Processo di preparazione di gabapentina
|
EP3067430B1
(fr)
|
2013-11-01 |
2020-08-12 |
Glytech, Inc. |
Procédé de production de dérivé d'acide aminé de forme d ou de forme l ayant un groupe thiol
|
SG11201604478UA
(en)
|
2013-12-17 |
2016-07-28 |
Esteve Labor Dr |
Gabapentinoids and sigma receptor ligands combinations
|
JP2016540771A
(ja)
|
2013-12-17 |
2016-12-28 |
ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ |
セロトニン−ノルアドレナリン再取り込み阻害薬(snri)およびシグマ受容体リガンドの組み合わせ
|
WO2015144825A1
(fr)
|
2014-03-27 |
2015-10-01 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Solution pharmaceutique liquide orale de gabapentine
|
US11213517B2
(en)
|
2016-12-16 |
2022-01-04 |
Idorsia Pharmaceuticals Ltd |
Pharmaceutical combination comprising a T-type calcium channel blocker
|
CA3079509C
(fr)
|
2018-07-04 |
2020-11-03 |
AMEZCUA AMEZCUA, Federico |
Combinaison medicamenteuse synergique de l'enantiomere actif (s)-ketorolac et de gabapentine pour le traitement de la douleur neuropathique
|
US10399926B1
(en)
|
2018-08-01 |
2019-09-03 |
Divi's Laboratories Ltd. |
Process for the preparation of gabapentin
|
KR20240110085A
(ko)
|
2018-10-11 |
2024-07-12 |
사니핏 테라퓨틱스 에스.에이. |
이소성 석회화의 치료를 위한 이노시톨 포스페이트
|
JPWO2021079887A1
(fr)
|
2019-10-25 |
2021-04-29 |
|
|
EP4015494A1
(fr)
|
2020-12-15 |
2022-06-22 |
Sanifit Therapeutics S.A. |
Procédés de préparation de sels solubles de phosphates d'inositol
|
GB2625579A
(en)
|
2022-12-21 |
2024-06-26 |
Novumgen Ltd |
An orally disintegrating tablet containing gabapentin or pharmaceutically acceptable salts thereof and the process of preparing the same
|